Hubei Goto Biopharm Co.,Ltd.

SZSE:300966.SZ

21.06 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -8.6663.5470.2215.31213.4484.0240.2712.93713.93613.04424.26513.02225.76615.27721.99812.60820.885-2.2030
Depreciation & Amortization 7.8277.82728.207-14.5237.9647.9647.567.566.4616.4616.0656.0655.6145.61421.183-10.46910.46900
Deferred Income Tax 000-21.98536.50800000000000000
Stock Based Compensation 1.40701.689-1.3761.37600000000000000
Change In Working Capital 9.6640-68.6737.883-37.8830-95.08362.331-62.3310-153.09953.099-53.0990-23.294-21.26421.26400
Accounts Receivables 1.6610-60.59515.7-15.70-34.65515.903-15.903020.2345.905-5.9050-66.311.48-11.4800
Change In Inventory 6.5960-9.76423.559-23.5590-60.42846.428-46.4280-173.33447.194-47.194043.006-32.74332.74300
Change In Accounts Payables 0000000000000000000
Other Working Capital 1.40701.689-1.3761.37600000000000000
Other Non Cash Items 74.829-27.76998.97243.507-3.424-69.38363.053-69.30265.13-43.14338.576-11.66-28.1314.245-20.48615.124-16.723-15.6180
Operating Cash Flow 58.337-24.22258.72948.8217.987-57.395-24.19913.52623.197-36.5656.777-4.703-7.97913.908-0.598-435.894-17.8210
Investing Activities:
Investments In Property Plant And Equipment -119.122-58.231-83.803-112.362-79.884-133.205-77.461-203.173-76.092-51.214-27.511-20.463-40.656-2.246-7.061-4.388-3.589-3.5290
Acquisitions Net 0.0050.09919.60-0.0230.02332.40.13413.216.216.3200000000
Purchases Of Investments 00000.023-0.023-32.4-19.2-13.302-14.42-2-14.5000000
Sales Maturities Of Investments 0000-15.00915.018-000.1020000000000
Other Investing Activites 0.0050.099-8.1242024.998-29.977-14.982-0.0180.102-14.4-0.037-0.1-14.5-2.246-7.057-4.324-0.02-3.52914.214
Investing Cash Flow -119.117-58.132-91.926-92.362-69.896-148.163-92.443-222.258-75.99-65.614-25.548-22.463-55.156-2.246-7.057-4.324-3.609-3.52914.214
Financing Activities:
Debt Repayment -231.19-48.38-10.686-70-103.48-115-92.748-57.75-35.833-64.114-4.022-62.219-33.73-56.79400-54.632-34.0630
Common Stock Issued 0000000000-13.97811.451-11.451000000
Common Stock Repurchased 000000-32.4000-20000-5.4000
Dividends Paid -5.122-3.095-4.56-2.889-0.513-8.278-2.794-1.531-19.48-3.102-1.802-2.456-1.679-1.639-1.895-2.119-2.59-2.560
Other Financing Activities 19.268-3.09519.62379.9370.826130.128415.8756.262338.415180.10134.74941.208236.11859.267-19.717-2.70635.82550-22.905
Financing Cash Flow 249.89745.28534.8697.04-33.1676.85320.328-3.018283.102112.88428.925-23.467200.7090.834-19.717-2.706-21.39713.377-22.905
Other Information:
Effect Of Forex Changes On Cash 0.7290.271-0.2370.138-0.2410.019-0.0960.3170.094-0.037-0.054-0.05-0.312-0.0210.224-0.138-0.012-0.0090
Net Change In Cash 187.507-36.7981.435-36.364-85.325-198.689203.589-211.432230.40310.67360.1-50.683137.26312.475-76.683-68.10610.876-7.981-8.691
Cash At End Of Period 304.359.42596.20694.771131.135216.46415.15211.561422.993192.59181.917121.816172.49935.236-26.774-7.02961.07650.201-8.691